april, 2020

2020thu16apr3:00 pm4:00 pmKetamine/Esketamine in the Treatment of Serious and Persistent Depression: Practical Considerations3:00 pm - 4:00 pm EST Event Type:OnlineSMI Adviser Event:YesAccredited Education Activity:Yes

Event Details

This webinar will briefly review the science and pharmacology that led to the development of ketamine and esketamine as a treatment for neuropsychiatric disorders. It will specifically focus on major issues to be contemplated when considering recommending treatment with ketamine or esketamine to treat severe and persistent major depressive disorder. We will critically review the existing data from a wide range of clinical trials and attempt to incorporate this data into clinical decision making processes.

Gerard Sanacora, PhD, MD, Yale University

For complete details visit: 


(Thursday) 3:00 pm - 4:00 pm

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts